Literature DB >> 23848818

BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia.

Ayse U Akarca, Vishvesh H Shende, Alan D Ramsay, Tim Diss, Maria Pane-Foix, Hasan Rizvi, Maria R Calaminici, Thomas M Grogan, David Linch, Teresa Marafioti.   

Abstract

Entities:  

Keywords:  haematological malignancies; immunocytochemistry; leukaemia diagnosis

Mesh：

Substances：

Year:  2013        PMID： 23848818     DOI： 10.1111/bjh.12429

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

2.  Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.

Authors:  Gabriele Pollara; Carolin T Turner; Joshua Rosenheim; Aneesh Chandran; Lucy C K Bell; Ayesha Khan; Amit Patel; Luis Felipe Peralta; Anna Folino; Ayse Akarca; Cristina Venturini; Tina Baker; Simone Ecker; Fabio L M Ricciardolo; Teresa Marafioti; Cesar Ugarte-Gil; David A J Moore; Benjamin M Chain; Gillian S Tomlinson; Mahdad Noursadeghi
Journal:  Sci Transl Med       Date:  2021-05-05       Impact factor: 17.956

Review 3.  BRAF Mutation in Hairy Cell Leukemia.

Authors:  Ahmad Ahmadzadeh; Saeid Shahrabi; Kaveh Jaseb; Fatemeh Norozi; Mohammad Shahjahani; Tina Vosoughi; Saeideh Hajizamani; Najmaldin Saki
Journal:  Oncol Rev       Date:  2014-09-23

Review 4.  Disease-specific mutations in mature lymphoid neoplasms: recent advances.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Yasuhisa Yokoyama; Shigeru Chiba
Journal:  Cancer Sci       Date:  2014-05-12       Impact factor: 6.716

5.  Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Authors:  Eleftheria Lakiotaki; Georgia Levidou; Maria K Angelopoulou; Christos Adamopoulos; Gerassimos Pangalis; George Rassidakis; Theodoros Vassilakopoulos; Gabriella Gainaru; Pagona Flevari; Sotirios Sachanas; Angelica A Saetta; Athanasia Sepsa; Maria Moschogiannis; Christina Kalpadakis; Nikolaos Tsesmetzis; Vassilios Milionis; Ilenia Chatziandreou; Irene Thymara; Panayiotis Panayiotidis; Maria Dimopoulou; Eleni Plata; Konstantinos Konstantopoulos; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 6.  Genomics of Hairy Cell Leukemia.

Authors:  Enrico Tiacci; Valentina Pettirossi; Gianluca Schiavoni; Brunangelo Falini
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

7.  Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells.

Authors:  Anna Śledzińska; Maria Vila de Mucha; Katharina Bergerhoff; Alastair Hotblack; Dafne Franz Demane; Ehsan Ghorani; Ayse U Akarca; Maria A V Marzolini; Isabelle Solomon; Frederick Arce Vargas; Martin Pule; Masahiro Ono; Benedict Seddon; George Kassiotis; Charlotte E Ariyan; Thomas Korn; Teresa Marafioti; Graham M Lord; Hans Stauss; Richard G Jenner; Karl S Peggs; Sergio A Quezada
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

8.  Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Am J Hematol       Date:  2017-12       Impact factor: 10.047

9.  Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.

Authors:  M Linch; G Goh; C Hiley; Y Shanmugabavan; N McGranahan; A Rowan; Y N S Wong; H King; A Furness; A Freeman; J Linares; A Akarca; J Herrero; R Rosenthal; N Harder; G Schmidt; G A Wilson; N J Birkbak; R Mitter; S Dentro; P Cathcart; M Arya; E Johnston; R Scott; M Hung; M Emberton; G Attard; Z Szallasi; S Punwani; S A Quezada; T Marafioti; M Gerlinger; H U Ahmed; C Swanton
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

10.  Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment.

Authors:  Deborah Soong; Priyadarshini Kumar; Karan Jatwani; Jae Park; Ahmet Dogan; Justin Taylor
Journal:  JCO Precis Oncol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.